What may initially seem to be a paradox, there is a natural link between the future of precision medicine and population management. For the alignment to be successful, there are some key questions to be answered and diseases to be explored. This panel will discuss the latest plays to bridge the gaps and debate the most essential steps for streamlining the right care to the right populations, and ultimately to the right patient.
Moderator: Nirav Vakharia, MD, Associate Chief Quality Officer, Cleveland Clinic
Paula Guy, President & CEO, Salus Telehealth
Gerry McDougall, Partner, PricewaterhouseCoopers
J. Marc Overhage, MD, PhD, Chief Health Information Officer, Population Health, Cerner
Kathryn Teng, MD, Physician Director, Adult Health & Wellness Service Line
Division Chief, General Internal Medicine & Community Medicine, MetroHealth
The orthopaedic field has taken a leading role in making value-based care work for all stakeholders. Technologies like surgical planning software, implant sensors, and robotics are being developed to tailor treatments for patients to improve outcomes and lower costs. Experts on this panel will discuss the status of these technologies and the latest market strategies to scale these precision-based approaches.
Moderator: Joseph Iannotti, MD, PhD,Chair, Orthopaedic & Rheumatologic Institute, Cleveland Clinic
Wael Barsoum, MD, President, Cleveland Clinic Florida
Mike Mont, MD, Orthopaedic & Rheumatologic Institute, Cleveland Clinic
Martin Roche, MD, Chief of Orthopaedics, Holy Cross Hospital
Patients might be a little surprised to learn how little physicians and scientists know how drugs work, let alone whether they will work or not work for certain patients. For many neurological diseases, for example, physicians have little choice but to use trial and error until the patient reports improvement. Pharmacogenomics is changing this as we speak. Experts on this panel will discuss the tremendous strides in using genomics to predict how patients will respond to medications. They will also attempt to answer the inevitable question: who is going to pay for it?
Moderator: Casey Cunningham, MD,CSO, Sante Ventures
Ryan Hansen, Executive Director, Avera Institute for Human Genetics
Yatin Mundkur, CEO, Cellworks
Ioannis Sapountzis, PhD Head, BD&L USA & Specialty Care, Boehringer Ingelheim
Mark Verratti, President, Assurex Health
It’s impossible to discuss genomics and precision medicine without discussing ethics. Experts will facilitate an exchange of ideas between all attendees regarding the ethics of Genetic Engineering, Direct-to-Consumer genetic information, and the privacy of data at the clinical and consumer level.
Keynote: Jeffrey Kahn, PhD, Director, Johns Hopkins Berman Institute of Bioethics
Katrine Bosley, CEO, Editas Medicine
Charlie Lougheed, Co-Founder & former President, Explorys, an IBM Company
For many, the concept of neuromodulation (one example being Deep Brain Stimulation), seems to be a one-size-fits-all approach for diseases like Parkinson’s, chronic pain, depression, and stroke. While the field is still growing, many are looking at the ways to predict patient responses to the use of electrodes. This panel will look at the opportunities to target populations and precisely alter individual therapies to garner the best outcomes, and how these tactics can build upon the DBS market’s ever-growing momentum.
Moderator: David Cassak, Managing Partner, Innovation in Medtech LLC
Rafael Carbunaru, Vice President of R&D, Neuromodulation, Boston Scientific Corp.
Andre Machado, MD, PhD, Chair, Neurological Institute
Lalit Venkatesan, PhD,
Director & Sr. Associate Research Fellow, Neuromodulation R&D, Abbott Neuromodulation
We are already navigating a sea of big data. Yet, if researchers get their wish of sequencing a million genomes in the next few years, one thing is clear: we’re going to need a bigger boat. Panelists will discuss the latest in cloud computing and analytics, and what it will take to activate this trove of information.
Moderator: Steve McHale, Emeritus Chairman, CEO, Explorys, an IBM Company
Aashima Gupta, Global Head, Healthcare Solutions, Google Cloud Platform, Google
Nabil Hafez, Senior Director Product Management Molecular & Genetic Solution, Sunquest Information Systems
Anil Jain, MD, VP & Chief Health Informatics Officer, IBM Watson Health
Peter Tippett, MD, PhD, Founder & CEO, HealthCelerate
Consumers are showing more interest than ever in their personal data and genetic makeup. Panelists will discuss this new consumer market, and how these new services will integrate with health systems and primary care physicians.
Moderator: Ed Marx, CIO, Cleveland Clinic
Peter Antall, MD, CMO, American Well
Drew Schiller, CEO & Co-founder, Validic
Wilson Tang, MD, Director, Center for Clinical Genomics, Cleveland Clinic
Robin Thurston, CEO, Helix
Carolyn Walsh, VP, Head of Sales and Business Development, FitBit Health Solutions
Is gene therapy making a comeback? How is RNA interference transforming medicine? Will we really be editing genes? These seemingly science-fiction approaches are already being used to treat diseases. Experts on this panel will look at the tremendous business opportunities and ethics surrounding CRISPR and Gene Therapy, while also looking at what these new powers could mean for humanity.
Moderator: Casey Cunningham, MD, CSO, Santé Ventures
Katrine Bosley, CEO, Editas Medicine
Christopher Miller, PhD, Director, Discovery, Genomics Research Center, Target Enabling Science & Technology, AbbVie
Akshay Vaishnaw, MD, PhD, EVP R&D, Alnylam
In this session, Dr. Tom Frazier of Autism Speaks will give a glimpse at the latest discoveries and innovation opportunities in our quest to better understand autism. Frazier will pull back the curtain on his personal journey as an autism parent and his family’s experience with genetic counseling.
Keynote: Tom Frazier, PhD, CSO, Autism Speaks
Guest: Allison Schreiber, Genetic Counselor, Cleveland Clinic
Patients are used to being on the sidelines when it comes to medical innovation. Yet, if precision medicine can truly take hold, the patient’s stories, needs, and expectations can no longer be overlooked. Panelists will discuss the trends for including patients and advocacy groups in the innovation process, the policies needed to protect their privacy, and technology’s role in delivering targeted, compassionate care.
Moderator: Kay Colby, Managing Producer, ideastream
Jody Holtzman, SVP, Market Innovation, AARP
Jennifer Leib, SVP, CRD Associates
James O’Leary, Chief Innovation Officer, Genetic Alliance
Daryl Pritchard, PhD, VP, Science Policy, Personalized Medicine Coalition
Devices that break down barriers were among the winning entries at this past weekend’s third annual Cleveland Medical Hack-a-thon.
Cleveland Clinic's Medical Innovation Summit, slated for Oct. 23 to Oct. 25 in downtown Cleveland, will focus on advancements in genomics and precision medicine.
Genomics and precision medicine will be the focus of Cleveland Clinic Medical Innovation Summit, taking place Monday through Wednesday, at the Huntington Convention Center in downtown Cleveland. Green is a featured speaker at the summit.
The Cleveland Medical Hackathon is Oct. 21-22 at the Global Center for Health Innovation in downtown Cleveland. Think of it as a prelude to the Cleveland Clinic Medical Innovation Summit, which begins Oct. 23 and runs through Oct. 25 at the same location.
This potentially transformative discipline is the subject of the Cleveland Clinic's Medical Innovation Summit, to be held Oct. 23-25 downtown. The summit is set to gather more than 2,000 health care and business leaders, among them Dr. Charis Eng, founder of the Clinic's Genomic Medicine Institute (GMI). Eng is a firm believer in the promise of genomics and precision medicine, having identified four of 10 genes known to be associated with breast cancer and another six connected to Cowden syndrome, a disorder that carries high risk of breast, thyroid and other cancers.
Gene therapy, artificial intelligence and customized implants are among the topics that will be discussed at the annual Cleveland Clinic's Medical Innovation Summit, coming this fall to downtown Cleveland.
Brain Power 2.0: The Business of Personalizing Neuromodulation
Building a Commercialization Ecosystem
Can Hospitals Handle the Truth? Turning Consumer Data into Clinical Action
Community Health forum: National Healthcare Transformation
Complete Picture: The Clinical & Commercial Promise of Image-Enabled Precision Medicine
Destiny Changing Technologies: Making Sense of Gene Therapy, Gene Silencing, and Gene Editing Markets
Feeding Your Genes: The Science and Business of Nutrigenomics
Genomics at the Bedside: Using Data & AI to Make Clinical Decisions
Gut Reaction: Harnessing the Market Potential of the Microbiome
Ideation Lab: Three Ethical Quandaries
Innovation in Action: A Fireside Chat
Made-to-Order Surgery: How 3D Printing is Revolutionizing the Operating Room
Maps, Models, and Robots: How Medtech is Personalizing Surgery
Minimizing Variation in Supply Chain through Physician Engagement
More Science, Less Art: An Industry Perspective on Pharmacogenomics
Orthopaedics 2020: A Market Analysis of Customized Surgeries
Patients First: Methods and Benefits of Bringing the Patient to the Innovation Table